Eyal Kalo
Technik-/Wissenschafts-/F&E-Leiter bei ESENSE-LAB LTD
Profil
Eyal Kalo is currently the Director of Research & Development at InnoCan Pharma Corp.
and the Chief Technology Officer at eSense-Lab Ltd.
He holds a doctorate degree from the Weizmann Institute of Science, which was conferred in 2010.
Aktive Positionen von Eyal Kalo
| Unternehmen | Position | Beginn |
|---|---|---|
| ESENSE-LAB LTD | Technik-/Wissenschafts-/F&E-Leiter | - |
| INNOCAN PHARMA CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2023 |
Ausbildung von Eyal Kalo
| Weizmann Institute of Science | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INNOCAN PHARMA CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
eSense-Lab Ltd.
 eSense-Lab Ltd. BiotechnologyHealth Technology eSense-Lab Ltd. engages in the research and development of terpene technology. It focuses on the creation of virtual plants through the reverse engineering of plants, and reconstruction of their essence using alternate natural products. It also specializes in the commercialization of the phytochemical profiling of plants, and combines genetics, messenger RNA (mRNA), protein expression, and phytochemical profiles to generate a model of targeted plants. The company was founded on April 13, 2016 and is headquartered in Ness Ziona, Israel. | Health Technology |